GL1X · GenesisL1 explorer

Research workbench

SARS-cov-2 papain-like protease (plpro) bound to inhibitor XR8-65

Analyse SARS-cov-2 papain-like protease (plpro) bound to inhibitor XR8-65 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7LOS
Type
protein
Length
632 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Non-structural protein 3
EC
3.4.19.12
UniProt
P0DTC1
Ligands
Y97, ZN, SO4, CL
Pockets
8 · best druggability 0.49

Structure

x-ray diffraction · 1 distinct chain · 26% helix, 35% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BNon-structural protein 3 (EC 3.4.19.12)protein31626% helix, 35% strandP0DTC1

Ligands and binding sites

  • Y97 · 5-(azetidin-3-ylamino)-2-methyl-~{N}-[(1~{R})-1-[3-[5-[[[(3~{R})-oxolan-3-yl]amino]methyl]thiophen-2-yl]phenyl]ethyl]benzamide · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 6 copies · chains A, B
  • CL · Chloride ion · ion · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11680.490.7729empty
2630.450.8212empty
31730.450.7526empty
4610.440.8213empty
5800.390.7819Y97

Interfaces

1 interface between chains.

  • A–B · 301 Ų buried · 9 hydrogen bonds · protein-protein

Compared structures

  • 7LOS · SARS-CoV-2 papain-like protease (PLpro) bound to inhibitor XR8-65 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.